Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dipyridamole on the pharmacokinetics of metformin
2012-000363-24Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), transient ischaemic attack (TIA) and ischemic stroke (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Metformin AUC and Cmax. Started Feb 2012; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)transient ischaemic attack (TIA)ischemic stroke
Beyond the preview
Go deeper on 2012-000363-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000363-24.